Coston McIsaac & Partners’s Dimensional US Targeted Value ETF DFAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97K Hold
1,401
0.02% 239
2026
Q1
$87K Sell
1,401
-46
-3% -$2.92K 0.02% 241
2025
Q4
$86K Hold
1,447
0.02% 244
2025
Q3
$84K Hold
1,447
0.02% 242
2025
Q2
$78K Buy
1,447
+1
+0.1% +$51 0.02% 239
2025
Q1
$74K Buy
1,446
+4
+0.3% +$220 0.02% 223
2024
Q4
$80K Buy
1,442
+5
+0.3% +$286 0.02% 218
2024
Q3
$79K Buy
1,437
+6
+0.4% +$324 0.02% 215
2024
Q2
$74K Buy
1,431
+5
+0.4% +$262 0.02% 212
2024
Q1
$77K Buy
1,426
+3
+0.2% +$154 0.02% 208
2023
Q4
$74K Buy
1,423
+6
+0.4% +$281 0.03% 208
2023
Q3
$64K Buy
1,417
+5
+0.4% +$237 0.02% 215
2023
Q2
$65K Buy
1,412
+50
+4% +$2.19K 0.02% 224
2023
Q1
$60K Buy
1,362
+4
+0.3% +$185 0.02% 236
2022
Q4
$59K Buy
1,358
+6
+0.4% +$264 0.02% 242
2022
Q3
$52K Buy
1,352
+4
+0.3% +$171 0.02% 209
2022
Q2
$54K Buy
+1,348
New +$59.1K 0.03% 129

Other funds holding DFAT

Coston McIsaac & Partners's DFAT Position: Q2 2026 in Review

Coston McIsaac & Partners held its Dimensional US Targeted Value ETF (DFAT) position steady in Q2 2026 at 1,401 shares worth $97K. The position accounts for 0.02% of the portfolio, ranked #239.

Coston McIsaac & Partners first reported a position in DFAT in Q2 2022 and has held it in 17 quarters since. 860 funds tracked by Wall St. Rank hold DFAT as of Q2 2026.

  • Coston McIsaac & Partners held 1,401 shares of Dimensional US Targeted Value ETF worth $97K as of Q2 2026.
  • Coston McIsaac & Partners left its Dimensional US Targeted Value ETF share count unchanged in Q2 2026.
  • Dimensional US Targeted Value ETF made up 0.02% of Coston McIsaac & Partners's portfolio in Q2 2026, its #239 holding.
  • Coston McIsaac & Partners first reported a position in Dimensional US Targeted Value ETF in Q2 2022 and has held it in 17 quarters since.
  • 860 funds tracked by Wall St. Rank held Dimensional US Targeted Value ETF as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.